![]()
businesswire | Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data |
yahoo | Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals |
yahoo | Arcturus Therapeutics to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Corporate Update on March 1, 2021 |
bloomberg | Thailand Approves AstraZeneca: Southeast Asia Vaccine Tracker |
fool | Is Arcturus Therapeutics a Buy? |
fool | Why Arcturus Therapeutics Stock Skyrocketed Today |
fool | Did You Miss Out on the Chance for Big Gains from Arcturus Stock? |
yahoo | Arcturus Therapeutics to Present at Upcoming Investor Conference |
fool | Why Is Everyone Talking About Arcturus Therapeutics Stock? |
yahoo | Outlook for biotech companies in 2021 |
marketwatch | Arcturus gets FDA go-ahead to begin Phase 2 trial for COVID-19 vaccine candidate |
yahoo | Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 Vaccine Candidate in the United States - Yahoo Finance |
yahoo | Arcturus to Develop ARCT-032 for Cystic Fibrosis |
thestreet | Arcturus to Develop Therapeutic Spray for Cystic Fibrosis |
yahoo | Biotech Stock Roundup: REGN Provides COVID-19 Updates, MYOV Partners With PFE & More |
zacks | Arcturus' Shares Fall on COVID-19 Vaccine Study Results |
yahoo | Arcturus Therapeutics to Advance ARCT-032, an Aerosolized LUNAR® mRNA-based Therapeutic, as a Development Candidate for Cystic Fibrosis Lung Disease |
fool | Markets Ease Lower as Arcturus, Blink Charging Plunge |
fool | Arcturus Reports Results From Early-Stage Testing of Its Coronavirus Vaccine |
yahoo | Tuesday’s 10 Notable Market Movers in the Limelight |
fool | Why Arcturus Therapeutics Stock Is Plunging Today |
investors | Why Arcturus Therapeutics Stock Crumbled On Its Covid Vaccine Update |
thestreet | Arcturus Slumps Amid Analyst Pessimism on Vaccine |
barrons | Novavax Starts a Phase 3 Trial for Its Covid Vaccine, While Arcturus Gets 5 Downgrades for Its Stock |
marketwatch | Arcturus Therapeutics shares slide 37% in premarket after COVID vaccine data are deemed ‘underwhelming’ |
yahoo | Arcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data |
fool | Why Arcturus Therapeutics Stock Is Sinking Today |
fool | 3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now |
insidermonkey | Is ARCT A Good Stock To Buy? |
fool | 3 COVID-19 Vaccine Stocks That Could Be the Biggest Winners in a Post-Pandemic World |
fool | These 2 Early-Stage COVID Vaccines Could Be Game-Changers |
fool | Is It Too Late to Get in on This Millionaire-Maker Stock? |
